UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer Journal article
Mahadevappa R., Neves H., Yuen S.M., Jameel M., Bai Y., Yuen H.-F., Zhang S.-D., Zhu Y., Lin Y., Kwok H.F.. DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer[J]. Cancers, 2018, 10(9).
Authors:  Mahadevappa R.;  Neves H.;  Yuen S.M.;  Jameel M.;  Bai Y.; et al.
Favorite | TC[WOS]:32 TC[Scopus]:32 | Submit date:2018/12/19
Breast Cancer  Knockdown  Mcm10  Overexpression  Proliferation  Survival  
Triggering of cancer cell cycle arrest by a novel scorpion venom-derived peptide -- Gonearrestide Journal article
Li, B., Lyu, P., Xi, X., Mahadevappa, R., Ge, L., Shaw, C., Kwok, H. F.. Triggering of cancer cell cycle arrest by a novel scorpion venom-derived peptide -- Gonearrestide[J]. Journal of Cellular and Molecular Medicine, 2018, DOI:10.1111/jcmm.13745---.
Authors:  Li, B.;  Lyu, P.;  Xi, X.;  Mahadevappa, R.;  Ge, L.; et al.
Favorite |  | Submit date:2022/06/02
Venom library  NGS transcriptome  MS/MS proteome  Anticancer mechanism  Signaling pathways  Binding sites  
Venom-based peptide drug discovery: enhancing specificity in cancer treatment Presentation
报告日期: 2017-09-06
Authors:  Li, B.;  Lyu, P.;  Ma, R.;  Mahadevappa, R.;  Xi, X.; et al.
Favorite |  | Submit date:2022/06/02
Venom peptides -- Improving specificity for cancer therapy Journal article
Mahadevappa, R., Ma, R., Kwok, H. F.. Venom peptides -- Improving specificity for cancer therapy[J]. Trends in Cancer, 2017, 611-614.
Authors:  Mahadevappa, R.;  Ma, R.;  Kwok, H. F.
Favorite |  | Submit date:2022/06/02
Venom Peptides  Targeted Cancer Therapy  Immunotherapy  Combinatorial Anticancer Drugs